Results 151 to 160 of about 14,105 (264)
Nuclear sphingomyelin in neurodegenerative diseases
Elisabetta Albi, Alice V Alessenko
openaire +3 more sources
ABSTRACT Background Abnormal accumulation of lipids within the kidney contributes to the progression of chronic kidney disease, but the underlying metabolic mechanisms remain unclear. Citrate is a central metabolite in cellular energy regulation and is frequently elevated in advanced kidney disease, yet its impact on renal lipid metabolism has not been
Marta Sanz‐Gómez +8 more
wiley +1 more source
Liquid chromatography tandem mass spectrometry and mass spectrometry imaging were used in combination with deuterium oxide administration to quantify and localise newly synthesised myelin lipids in the mouse brain. This methodology, used here to show sites of myelin repair, enables the measurement of dynamic lipid synthesis in living systems and ...
Catherine Zhang +7 more
wiley +2 more sources
Candidate blood biomarkers linked with feed intake efficiency and weight gain in sheep. [PDF]
Osonowo O +9 more
europepmc +1 more source
Increases in sphingomyelin in response to TDP‐43 pathology in the disease‐affected motor cortex of amyotrophic lateral sclerosis (ALS) brain. Abstract Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease characterized by the degeneration of motor neurons and the presence of TAR DNA‐binding protein 43 (TDP‐43 ...
Finula I. Isik +4 more
wiley +1 more source
Association Between Human Milk-Targeted Metabolites and Maternal Characteristics: Targeted Metabolomic Profiling of Human Milk in Low-Income Settings. [PDF]
Parkar S +10 more
europepmc +1 more source
ABSTRACT Aims Circadian regulation of metabolism is an important factor in metabolic health, yet the role of rhythmic metabolites in Type 2 diabetes development remains poorly understood. This study investigated associations between circulating rhythmic metabolites and incident Type 2 diabetes risk and evaluated causal relationships using two‐sample ...
Divya Joshi +10 more
wiley +1 more source
Altered plasma sphingomyelins (SMs) have been implicated in Alzheimer's disease (AD), pointing to disturbances in lipid metabolism that may contribute to disease pathogenesis. Neuronal damage in early AD triggers tau release into central and peripheral systems, with plasma total tau (T‐tau) remaining a valuable marker for AD‐related neurodegeneration ...
Tahmida Sharmin +9 more
wiley +1 more source
Gut sphingolipid composition as a prelude to necrotizing enterocolitis [PDF]
Jiang, X. +5 more
core +1 more source

